139 related articles for article (PubMed ID: 37013288)
21. The association between nonalcoholic fatty pancreas disease and diabetes.
Ou HY; Wang CY; Yang YC; Chen MF; Chang CJ
PLoS One; 2013; 8(5):e62561. PubMed ID: 23671610
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of endoscopic ultrasound, multidetector computed tomography, and magnetic resonance cholangiopancreatography in the diagnosis of pancreas divisum: a tertiary center experience.
Kushnir VM; Wani SB; Fowler K; Menias C; Varma R; Narra V; Hovis C; Murad FM; Mullady DK; Jonnalagadda SS; Early DS; Edmundowicz SA; Azar RR
Pancreas; 2013 Apr; 42(3):436-41. PubMed ID: 23211370
[TBL] [Abstract][Full Text] [Related]
23. Impact of qualitative endoscopic ultrasonography on fatty pancreas at a referral medical center.
Kawamura A; Takakura K; Torisu Y; Kinoshita Y; Tomita Y; Nakano M; Yamauchi T; Suka M; Sumiyama K; Koido S; Saruta M
JGH Open; 2022 Jan; 6(1):44-49. PubMed ID: 35071787
[TBL] [Abstract][Full Text] [Related]
24. Non-alcoholic fatty pancreas disease.
Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
[TBL] [Abstract][Full Text] [Related]
25. Delay in Pancreatic Endoscopic Ultrasound During the COVID-19 Pandemic in a Pancreas/Tertiary Referral Center.
Zaccari P; Tacelli M; Petrone MC; Capurso G; Arcidiacono PG
Pancreas; 2021 Jul; 50(6):e54-e55. PubMed ID: 34347729
[No Abstract] [Full Text] [Related]
26. Nonalcoholic fatty pancreas disease: An emerging clinical challenge.
Zhang CL; Wang JJ; Li JN; Yang Y
World J Clin Cases; 2021 Aug; 9(23):6624-6638. PubMed ID: 34447810
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic hyperechogenicity on endoscopic ultrasound examination.
Ustundag Y; Ceylan G; Hekimoglu K
World J Gastroenterol; 2011 Apr; 17(15):2061-2. PubMed ID: 21528089
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Pancreatic Steatosis at a Pediatric Tertiary Care Center.
Pham YH; Bingham BA; Bell CS; Greenfield SA; John SD; Robinson LH; Eissa MA
South Med J; 2016 Mar; 109(3):196-8. PubMed ID: 26954660
[TBL] [Abstract][Full Text] [Related]
29. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
[TBL] [Abstract][Full Text] [Related]
30. Frequency and risk factors in the post-ERCP pancreatitis in a tertiary care centre.
Leghari A; Ghazanfar S; Qureshi S; Taj MA; Niaz SK; Quraishy MS
J Coll Physicians Surg Pak; 2013 Sep; 23(9):620-4. PubMed ID: 24034184
[TBL] [Abstract][Full Text] [Related]
31. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.
Wong VW; Wong GL; Yeung DK; Abrigo JM; Kong AP; Chan RS; Chim AM; Shen J; Ho CS; Woo J; Chu WC; Chan HL
Am J Gastroenterol; 2014 Apr; 109(4):589-97. PubMed ID: 24492753
[TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study.
Napoleon B; Alvarez-Sanchez MV; Gincoul R; Pujol B; Lefort C; Lepilliez V; Labadie M; Souquet JC; Queneau PE; Scoazec JY; Chayvialle JA; Ponchon T
Endoscopy; 2010 Jul; 42(7):564-70. PubMed ID: 20593334
[TBL] [Abstract][Full Text] [Related]
33. A prospective evaluation of fatty pancreas by using EUS.
Sepe PS; Ohri A; Sanaka S; Berzin TM; Sekhon S; Bennett G; Mehta G; Chuttani R; Kane R; Pleskow D; Sawhney MS
Gastrointest Endosc; 2011 May; 73(5):987-93. PubMed ID: 21521567
[TBL] [Abstract][Full Text] [Related]
34. The Clinical Implications of Fatty Pancreas: A Concise Review.
Khoury T; Asombang AW; Berzin TM; Cohen J; Pleskow DK; Mizrahi M
Dig Dis Sci; 2017 Oct; 62(10):2658-2667. PubMed ID: 28791556
[TBL] [Abstract][Full Text] [Related]
35. Fatty Pancreas Represents a Risk Factor for Acute Pancreatitis: A Pilot Study.
Sbeit W; Khoury T
Pancreas; 2021 Aug; 50(7):990-993. PubMed ID: 34629451
[TBL] [Abstract][Full Text] [Related]
36. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
[TBL] [Abstract][Full Text] [Related]
37. [NON-ALCOHOLIC FATTY PANCREATIC DISEASE (NAFPD) AND THE METABOLIC SYNDROME: INITIATING FACTOR OR ADDITIONAL COMPONENT?].
Grigorieva IN; Efimova OV; Tov NL; Suvorova TS
Eksp Klin Gastroenterol; 2015; (9):86-91. PubMed ID: 26931016
[TBL] [Abstract][Full Text] [Related]
38. The importance of endoscopic ultrasound fine-needle aspiration in the diagnosis of solid pseudopapillary tumor of the pancreas: two case reports.
De Moura DTH; Coronel M; Ribeiro IB; Farias GFA; Choez MA; Rocha R; Toscano MP; De Moura EGH
J Med Case Rep; 2018 Apr; 12(1):107. PubMed ID: 29695287
[TBL] [Abstract][Full Text] [Related]
39. Detection of embryologic ventral pancreatic parenchyma with endoscopic ultrasound.
Savides TJ; Gress FG; Zaidi SA; Ikenberry SO; Hawes RH
Gastrointest Endosc; 1996 Jan; 43(1):14-9. PubMed ID: 8903811
[TBL] [Abstract][Full Text] [Related]
40. Yield of endoscopic ultrasound-guided fine needle aspiration and endoscopic retrograde cholangiopancreatography for solid pancreatic neoplasms.
Malak M; Masuda D; Ogura T; Imoto A; Abdelaal UM; Sabet EA; Abo Dahab LH; Higuchi K
Scand J Gastroenterol; 2016 Mar; 51(3):360-7. PubMed ID: 26365063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
